Connect with us

COVID-19

Doctors don’t know how many COVID shots to order for children due to plummeting interest

Published

5 minute read

From LifeSiteNews

By Calvin Freiburger

Just 15% of eligible children received COVID-19 shots in the 2023-2024 vaccination season, leaving pro-jab pediatricians struggling with how many doses to order for the fall.

Pediatricians across the United States are scaling back on their orders of updated COVID-19 vaccines for children after portions of previous stock went unused, and are opening up about their difficulty judging waning interest from parents.

MedPage Today reported that some doctors admit they’ve been reduced to “‘guessing” how much reformulated COVID vaccine to order after a paltry 15% of eligible children were vaccinated in the 2023-2024 season. Compounding the issue is that unused COVID shots often last shorter than other childhood vaccines.

“This is where we usually store our COVID vaccines, but we don’t have any right now because they all expired at the end of last year and we had to dispose of them,” Orange Country, California pediatrician Dr. Eric Ball said, opening a refrigerator of childhood shots. “We thought demand would be way higher than it was.”

“Watching it sitting on our shelves expiring every 30 days, that’s like throwing away $150 repeatedly every day, multiple times a month,” he continued, explaining that ordering just a bare minimum supply for the fall season still cost more than $63,000.

Adding to headaches is that the pharmaceutical giants behind the vaccines cannot be counted on to take back unused stock. Pfizer “will take back all unused COVID shots for young children, but only 30% of doses opens in a new tab or window for people 12 and older,” MedPage said. Moderna’s return policy varies on the basis of individual contracts with different providers.

“Pfizer is creating that situation. If you’re only going to let us return 30%, we’re not going to buy much,” South Carolina pediatrician Dr. Deborah Greenhouse said. “We can’t (…) Frankly, it’s not an ideal situation, but it’s what we have to do to stay in business.”

Doctors’ struggle to unload child COVID vaccine doses suggests, at a minimum, that parents are broadly rejecting the narrative that their children need to be immunized for COVID, if not necessarily widespread awareness of the shots’ risks.

Evidence finds that children face little-to-no-danger from COVID itself. In February 2024, the first interim report of a grand jury impaneled by Florida Gov. Ron DeSantis to investigate the COVID vaccines determined among other things that COVID was “statistically almost harmless” to children and most adults.

An analysis of 99 million people across eight countries published February in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID vaccines, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 vaccines and offered several theories for a causal link.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

WATCH: Big Pharma scientist admits COVID shot not ‘safe and effective’ to O’Keefe journalist

Published on

From LifeSiteNews

By Doug Mainwaring

‘None of that stuff was safe and effective. We didn’t do the typical tests,’ Joshua Rys of Johnson & Johnson said to one of James O’Keefe’s undercover journalists.

A lead scientist for a global pharmaceutical firm disclosed on hidden camera that his firm’s COVID-19 vaccine underwent rushed testing, lacked research, and admitted that, in direct contradiction to the Biden administration’s constant refrain, the drug was not “safe and effective.”

“None of that stuff was safe and effective. We didn’t do the typical tests,” said Joshua Rys, a lead regulatory affairs scientist for Johnson & Johnson (J&J), not realizing that he was being filmed by one of James O’Keefe’s undercover journalists.

Rys explained that normally a new drug undergoes an extended period of testing, including human trials, but the COVID-19 vaccine circumvented those safety measures in order to rush the product to the public.

“This was just, ‘Let’s test it on some lab-rat models, analyze and see if it works,” said Rys, “and just throw it to the wind and see what happens.”

“I’m sure somebody is going to get sued for that stuff, eventually,” he predicted.

“Do you have any idea [of] the lack of research that was done on those products?” asked the J&J lead scientist.

“People wanted it. We gave it to them,” said Rys.

O’Keefe later approached Rys to ask what led him to tell a total stranger that his product was not safe and effective, but Rys evaded O’Keefe and his probing. 

O’Keefe explained that the work of his O’Keefe Media Group (OMG) undercover journalists is crucial because, he claimed, up to 80 percent of the revenue cable and other news organizations derive from ads comes from Big Pharma.

Continue Reading

COVID-19

Japan disposes $1.6 billion worth of COVID drugs nobody used

Published on

From LifeSiteNews

By Calvin Freiburger

The nation’s health ministry has already trashed 2 million doses of PaxlovidPACK and Lagevrio, and will dispose of 1.77 million doses of Xocova by the end of February 2026.

Japan is disposing of $1.6 billion worth of COVID-19 drugs that went unused and are now expired in a dramatic disconnect between government projections and reality.

The Japanese Broadcasting Corporation reported that the nation’s health ministry has already trashed 1.75 million patients’ worth of PaxlovidPACK and 780,000 patients’ worth of Lagevrio doses, and will dispose of 1.77 million patients’ worth of Xocova by the end of February 2026.

The government had been required by law to purchase enough oral COVID drugs for 5.6 million people, to be distributed free of charge through May 2023, at which point the virus was downgraded to the same threat level as normal seasonal influenza. But 2.5 million, a little under half the supply, remained unused by the time they hit their expiration dates.

The Star added that the value of the destroyed drugs is estimated to be roughly 240 billion yen, or 1.6 billion US dollars.

Across the world, governments took drastic action to counter the COVID pandemic, based in large part on exaggerated assumptions about the virus’s transmissibility and threat to non-elderly individuals without comorbidities. A large body of evidence has found that mass restrictions on personal and economic activity undertaken in 2020 and part of 2021 caused far more harm than good in terms of personal freedom and economics as well as public health, and that lives could have been saved through far less burdensome methods, such as the promotion of established therapeutic drugs, narrower protections focused on those most at risk (such as the elderly and infirm), and increasing vitamin D intake.

In Florida, the first report by a grand jury impaneled by Republican Gov. Ron DeSantis determined that lockdowns did more harm than good, that masks were ineffective at stopping COVID transmission, that COVID was “statistically almost harmless” to children and most adults, and that it is “highly likely” that COVID hospitalization numbers were inflated.

Much like the controversial COVID vaccines, concerns were raised about the safety and effectiveness of COVID therapeutics such as Paxlovid and Lagevrio as well.

In May, former Japanese minister of internal affairs and communications Kazuhiro Haraguchi announced he had cancer, and said testing of the lesions linked it to spike proteins from the COVID-19 vaccine he had received two years before.

Continue Reading

Trending

X